Euroapi S.A. (OTCMKTS:EAPIF – Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 30th, there was short interest totaling 1,228 shares, a decrease of 95.6% from the October 15th total of 28,026 shares. Based on an average daily volume of 493 shares, the days-to-cover ratio is presently 2.5 days.
Euroapi Stock Performance
EAPIF stock opened at C$0.89 on Wednesday. Euroapi has a twelve month low of C$0.84 and a twelve month high of C$3.46. The stock’s 50 day moving average is C$0.95 and its 200-day moving average is C$1.47.
Euroapi Company Profile
Euroapi is a pharmaceutical ingredients company headquartered in France. It develops and manufactures active pharmaceutical ingredients (APIs), the substances that provide the therapeutic effect in medicines, and supplies them to pharmaceutical companies and other customers. The company offers a range of APIs as well as contract development and manufacturing services. Its work can support customers through different stages of product development and commercial production, including the manufacture of ingredients to customer specifications.
Further Reading
- Five stocks we like better than Euroapi
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Euroapi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euroapi and related companies with MarketBeat.com's FREE daily email newsletter.
